Biopharma Dive Alkeus
Biopharma Dive Alkeus entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.
Timeline
Thu, 06 Aug 2026 19:14:51 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive
Wed, 29 Jul 2026 07:00:00 GMTMapLight CEO on what investors missed in the biotech’s schizophrenia data - BioPharma Dive
Related explainers
Connected entities
FAQ
What does this page track?
Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biopharma Dive Alkeus.
Why might this page be noindex?
Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.
Where should readers verify facts?
Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.
Source diversity
1 distinct publisher/source names are currently connected to this entity page.